Startup Funding Tracker
Home›Companies›Biotech & Pharma›Sea Pharmaceuticals

Sea Pharmaceuticals, LLC

Develops potential oral medicines for people with tinnitus, epilepsy and sporadic ALS.

ActiveBiotech & Pharma · Therapeutics
Updated Nov 10, 2026·Latest SEC filing May 20, 2026·Suggest an edit

About Sea Pharmaceuticals

Sea Pharmaceuticals is a private company based in Cambridge, Massachusetts. It has reported $2,865,915 raised in five offerings on Form D since February 2016. Its chief executive is James Pearson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 17, 2025May 14, 2025amended May 20, 2026$71,100of $1.7M target7$10,157EquityRule 506(b)Form D/A ↗1 earlier filing
Dec 29, 2023Oct 11, 2023amended Feb 11, 2025$417,380of $2.1M target16$26,086EquityRule 506(b)Form D/A ↗1 earlier filing
Mar 13, 2019Feb 27, 2019amended Jan 26, 2023$1,490,435of $2.0M target27$55,201EquityRule 506(b)Form D/A ↗4 earlier filings
Not yetNov 17, 2017$0of $2.0M target0—EquityRule 506(b)Form D ↗
Feb 19, 2016Feb 29, 2016amended Nov 16, 2016$887,000of $3.5M target38$23,342EquityRule 506(b)Form D/A ↗1 earlier filing
Total, five offerings$2,865,915

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Sea Pharmaceuticals's Form D filed May 20, 2026.

MC
SS
JP
James Pearson
President, CEO, CSO, Investor, FTE, Founder and director
LinkedIn ↗
NE
Nabil Elkouh
Director
LinkedIn ↗
Also a chief executive officer and director at Conamix.
MH
WB
Walter Brown
Director
EO
Eric Olson
Director

Earlier filings also listed Benjamin Cravatt (director, last listed Jan 2023), W. Kendall Brown (director, last listed Nov 2017), Eduardo Martinez (vice president, last listed Nov 2017) and Anne Sullivan (executive officer, last listed Nov 2017).

Sources

  1. SECSea Pharmaceuticals, LLC Form D, filed May 14, 2025
  2. SECSea Pharmaceuticals, LLC Form D, filed Oct 11, 2023
  3. SECSea Pharmaceuticals, LLC Form D/A, filed Jan 14, 2022
  4. SECSea Pharmaceuticals, LLC Form D/A, filed Feb 1, 2021
  5. SECSea Pharmaceuticals, LLC Form D/A, filed Jan 31, 2020
  6. SECSea Pharmaceuticals, LLC Form D, filed Feb 27, 2019
  7. SECSea Pharmaceuticals, LLC Form D, filed Feb 29, 2016
  8. SECSea Pharmaceuticals, LLC filing history
  9. CompanyAbout Sea Pharmaceuticals
  10. CompanySea Pharmaceuticals team
  11. CompanySea Pharmaceuticals company update